Wencheng Q. Kong

Hangzhou, 310000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

MX1 is a novel crucial prognostic and therapeutic target inducing chemoresistance in right-sided colon cancer: insights from machine learning-based multi-omics analysis.

MX1 is a novel crucial prognostic and therapeutic target inducing chemoresistance in right-sided colon cancer: insights from machine learning-based multi-omics analysis.

Journal: Human genomics

Published: July 22, 2025

FOXP2 suppresses gastric cancer progression by transcriptionally repressing FBXW2 via WASL degradation.

FOXP2 suppresses gastric cancer progression by transcriptionally repressing FBXW2 via WASL degradation.

Journal: Cell death discovery

Published: May 08, 2025

Idiopathic hypereosinophilic syndrome complicated by computed tomography-negative cerebral infarction, strangulated intestinal obstruction, and hepatic portal venous gas: a case report of multi-system involvement.

Idiopathic hypereosinophilic syndrome complicated by computed tomography-negative cerebral infarction, strangulated intestinal obstruction, and hepatic portal venous gas: a case report of multi-system involvement.

Journal: Quantitative imaging in medicine and surgery

Published: May 07, 2025

Integrated muti-omics data and machine learning reveal CD151 as a key biomarker inducing chemoresistance in metabolic syndrome-related early-onset left-sided colorectal cancer.

Integrated muti-omics data and machine learning reveal CD151 as a key biomarker inducing chemoresistance in metabolic syndrome-related early-onset left-sided colorectal cancer.

Journal: Functional & integrative genomics

Published: April 04, 2025

USP10-mediated deubiquitination and activation of KRAS mutants promotes colorectal cancer via a novel USP10/KRAS positive feedback circuit.

USP10-mediated deubiquitination and activation of KRAS mutants promotes colorectal cancer via a novel USP10/KRAS positive feedback circuit.

Journal: Acta pharmaceutica Sinica. B

Published: February 22, 2025

Retraction of: Extracellular vesicle derived miR-544 downregulates expression of tumor suppressor promyelocytic leukemia zinc finger resulting in increased peritoneal metastasis in gastric cancer.

Retraction of: Extracellular vesicle derived miR-544 downregulates expression of tumor suppressor promyelocytic leukemia zinc finger resulting in increased peritoneal metastasis in gastric cancer.

Journal: Aging

Published: January 11, 2025

Relationship between AQP5 and chemotherapy resistance in colorectal cancer cells and its mechanism.

Relationship between AQP5 and chemotherapy resistance in colorectal cancer cells and its mechanism.

Journal: Discover oncology

Published: January 06, 2025

Traditional Chinese medicine for acute intracerebral haemorrhage.

Traditional Chinese medicine for acute intracerebral haemorrhage.

Journal: Lancet (London, England)

Published: November 22, 2024

[Retracted] Exosomal miR‑130a‑3p promotes the progression of differentiated thyroid cancer by targeting insulin‑like growth factor 1.

[Retracted] Exosomal miR‑130a‑3p promotes the progression of differentiated thyroid cancer by targeting insulin‑like growth factor 1.

Journal: Oncology letters

Published: September 04, 2023

Tremella fuciformis polysaccharides induce ferroptosis in Epstein-Barr virus-associated gastric cancer by inactivating NRF2/HO-1 signaling.

Tremella fuciformis polysaccharides induce ferroptosis in Epstein-Barr virus-associated gastric cancer by inactivating NRF2/HO-1 signaling.

Journal: Aging

Published: July 13, 2023

Factors influencing the detection rate of fumarate peak in 1H MR spectroscopy of fumarate hydratase-deficient renal cell carcinoma at 3 T MRI.

Factors influencing the detection rate of fumarate peak in 1H MR spectroscopy of fumarate hydratase-deficient renal cell carcinoma at 3 T MRI.

Journal: Clinical radiology

Published: January 12, 2023

Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer.

Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer.

Journal: Frontiers in pharmacology

Published: January 02, 2023

Showing 1-12 of 48

Last Updated: 09/26/2026